SESSION TITLE: Mechanical Ventilation & Respiratory Failure II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Dexmedetomidine (DEX), a selective alpha-2-adrenergic receptor agonist, possesses sedative, analgesic and anxiolytic properties without causing significant respiratory depression in mechanically ventilated (MV) patients. In MV patients who are difficult to wean off of sedation secondary to agitation, DEX may be able to shorten time to extubation. The purpose of this study is to assess the percentage of MV patients deemed difficult to extubate secondary to agitation that were successfully extubated within 48 hours after initiation of DEX therapy.